Evidence map›Paper›PMID 40697764›Full record

ArticlePediatric gastroenterology, hepatology & nutrition2025

Comparison of Polyethylene Glycol 3350+Electrolytes vs. Polyethylene Glycol 4000 for Fecal Disimpaction in Pediatric Functional Constipation: A Double-Blind Randomized Controlled Trial.

Kalpana Panda, J Bikrant Kumar Prusty, Mrutunjay Dash, Basudev Biswal, Mamata Devi Mohanty, Prasant Kumar Saboth

Abstract read
In one paragraph

Article in Pediatric gastroenterology, hepatology & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kalpana PandaDivision of Pediatric Gastroenterology and Hepatology, Department of Pediatric, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.ORCID https://orcid.org/0000-0002-7280-5743
J Bikrant Kumar PrustyDepartment of Pediatric, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.ORCID https://orcid.org/0000-0002-9326-7163
Mrutunjay DashDepartment of Pediatric, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.ORCID https://orcid.org/0000-0002-9718-500X
Basudev BiswalDepartment of Pediatric, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.ORCID https://orcid.org/0000-0002-2418-5754
Mamata Devi MohantyDepartment of Pediatric, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.ORCID https://orcid.org/0000-0002-2638-8280
Prasant Kumar SabothDepartment of Pediatric, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha, India.ORCID https://orcid.org/0000-0003-4966-8821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Polyethylene glycol (PEG) is recommended as the first-line laxative for fecal disimpaction in pediatric functional constipation. PEG 3350+electrolyte (E) and PEG 4000 are the most commonly available formulations. PEG 3350+E and PEG 4000 have hypothesized benefits of lower risk of electrolyte imbalance and better palatability, respectively. However, a head-to-head comparison of these two formulations for fecal disimpaction remains lacking. This study aimed to compare the efficacy, tolerability, and acceptability of PEG 3350+E vs. PEG 4000 for fecal disimpaction in pediatric functional constipation. Methods: This double-blind, randomized controlled intention-to-treat trial included pediatric patients with functional constipation (as per ROME IV) and fecal impaction. Patients with organic constipation, h/o prior to gastrointestinal surgery, and those who were already receiving PEG/lactulose were excluded. Computer-generated block randomization was performed. Colorless liquid formulations of study medication were provided by investigator (JBK) as per treatment allocation in identical opaque bottles @1.5 gm/kg/dayx6 days or until fecal impaction resolution (passage of clear liquid stool), whichever is earlier. Results: One hundred patients were randomized in a 1:1 ratio (50 patients in each arm). Efficacy of PEG 3350+E vs. PEG 4000 was similar (84% vs. 86%; Conclusion: PEG 3350+E and PEG 4000 showed similar efficacies for fecal disimpaction, with minor side effects. PEG 4000 had better palatability; however, both were well tolerated by children.

Indexed as

ConstipationFecal impactionPediatricsPolyethylene glycols

Identifiers

PMID40697764
PMCPMC12277857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.